A 65-year-old white woman complained of an increasingly sore throat despite tr eatment with a twicedaily proton-pump inhi bitor and a daily H, blocker for laryngopharyngeal reflux (LPR). Her his-tory was significant for chronic obstructive pu lmo nary disease (COPD); laryngeal leukoplakia had been diagnos ed 16 years earlier. She had also experienced two previous episodes of "laryngeal thrush" that had been successfully treated with an oral antifungal. Her daily medication regimen included an inhaled steroid for her COPD. She had recen tly quit a pack-a-day cigarette habit.
On strobovideolaryngoscopy, the patient exhibited signs consistent with LPR, as well as moderate to severe edema and erythema of the supraglottic and glot -tic mucosal surfaces. White, lacy plaques were seen diffusely embedded in the inflamed mucosal surfaces ( figure) . The diagnosis of laryngeal candidiasis was made clinically, and the patient was prescribed nystatin an tifunga l solution ("swish and swallow") and 100 mg/day of ora l fluconazo le. At follow-up 2 weeks later, the fungal laryngitis had resolved.
When the patient returned for routine leukoplakia sur veillance 3 months later, she exhib ited a recurrence of the candidiasis. She was restarted on fluconazole, and the infectio n again resolved. She was counseled that her propensity to develop fungal infections of the larynx was attributable to her use of inhaled corticosteroids for COPD. She was advised to talk with her pulmo nologist about switching from inha led to oral therapy. The presence of fungal laryngeal infectio ns can m imic gastroesophageal reflux disease, granulomatous diseases, leukoplakia, and carcinoma. Although mycotic infections of the larynx are typically considered to be associated with immunocompromise, such infections can occur in immunocompetent hosts in whom there are alterations in the mucosal barrier.I Conditio ns . such as LPR, which produces mucosal injury throu gh retrograde acid transit through the esophagus, may predispose to funga l laryngitis. The administration of antibiotics, which leads to alteration of the native bacterial flora, allows for overgrowth of Candida organisms, which are found in th e normal ora l flora in 7% of the population.' Inhaled steroids also represent a risk for the development of oral, pharyngeal, and laryngeal candidiasis secondary to local immunosuppression.
Stro bovideolaryngoscopy plays an important role in the diagnosis of laryngeal candidiasis. Althoug h nonspecific, a finding of diffuse mu cosal edema and erythema despite adequate LPR the rapy should prompt consideration of fungal laryngitis. Furthermore, the typica l finding of a white or gray pseudomembrane on an inflamed mucosa often indica tes fungal laryngitis. Some authors advocate biopsy of the mucosa for adequate diagnosis, but we have previously demonstrated that a strong clinical suspicion and an adequate treatment response can confirm the diagnosis . In the case of an incomplete response or a suspicion of malignancy, a biopsy sho uld be considered.'
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